Fig. 1.
Fig. 1. Morphology of erythroblasts from normal donors and patients with DBA. Cytocentrifuge preparations were prepared from day 10 and 14 BFU-E–derived erythroblasts cultured with or without 100 ng/mL SCF. BFU-E–derived erythroblasts from a representative normal donor are shown at day 10 (A, −SCF; B, +SCF ), and day 14 (C, −SCF; D, +SCF ) and from a patient with transfusion-dependent DBA at day 10 (E, −SCF; F, +SCF ) and 14 (G, −SCF; H, +SCF ) of maturation. Preparations made from three additional patients and normal donors showed similar results.

Morphology of erythroblasts from normal donors and patients with DBA. Cytocentrifuge preparations were prepared from day 10 and 14 BFU-E–derived erythroblasts cultured with or without 100 ng/mL SCF. BFU-E–derived erythroblasts from a representative normal donor are shown at day 10 (A, −SCF; B, +SCF ), and day 14 (C, −SCF; D, +SCF ) and from a patient with transfusion-dependent DBA at day 10 (E, −SCF; F, +SCF ) and 14 (G, −SCF; H, +SCF ) of maturation. Preparations made from three additional patients and normal donors showed similar results.

Close Modal

or Create an Account

Close Modal
Close Modal